Portfolio (Quarterly)
Guide ↗
CAXTON CORP
· CIK 0001388551| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GLD | SPDR GOLD TR | Financial Services | 7,623.0 | $3.3M | 81.50% | +659.0 | +9.5% | $430.27 | -0.7% |
| 2 | — | BERKSHIRE HATHAWAY INC DEL | — | 727.0 | $348K | 8.66% | +17.0 | +2.4% | $479.15 | — |
| 3 | KYTX | KYVERNA THERAPEUTICS INC | Healthcare | 18,773.0 | $162K | 4.03% | — | — | $8.63 | +24.4% |
| 4 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 13,943.0 | $80K | 1.99% | — | — | $5.74 | -4.2% |
| 5 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 15,557.0 | $64K | 1.60% | — | — | $4.13 | -4.6% |
| 6 | — | INHIBIKASE THERAPEUTICS INC | — | 28,453.0 | $48K | 1.19% | — | — | $1.68 | — |
| 7 | ALXO | ALX ONCOLOGY HLDGS INC | Healthcare | 20,946.0 | $42K | 1.04% | NEW | — | $2.00 | +1.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Financial Services
90.4%
Healthcare
9.6%